Review

Centrosome-associated regulators of the G₂/M checkpoint as targets for cancer therapy

Yingmei Wang^1,2 , Ping Ji² , Jinsong Liu² , Russell R Broaddus² , Fengxia Xue¹ and Wei Zhang²

¹  Tianjin General Hospital, Tianjin Medical University, Tianjin 300052, PR China

²  Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA

author email corresponding author email

Molecular Cancer 2009, 8:8doi:10.1186/1476-4598-8-8

Published:	13 February 2009

Abstract

In eukaryotic cells, control mechanisms have developed that restrain cell-cycle transitions in response to stress. These regulatory pathways are termed cell-cycle checkpoints. The G₂/M checkpoint prevents cells from entering mitosis when DNA is damaged in order to afford these cells an opportunity to repair the damaged DNA before propagating genetic defects to the daughter cells. If the damage is irreparable, checkpoint signaling might activate pathways that lead to apoptosis. Since alteration of cell-cycle control is a hallmark of tumorigenesis, cell-cycle regulators represent potential targets for therapy. The centrosome has recently come into focus as a critical cellular organelle that integrates G₂/M checkpoint control and repairs signals in response to DNA damage. A growing number of G₂/M checkpoint regulators have been found in the centrosome, suggesting that centrosome has an important role in G₂/M checkpoint function. In this review, we discuss centrosome-associated regulators of the G₂/M checkpoint, the dysregulation of this checkpoint in cancer, and potential candidate targets for cancer therapy.